We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » RENAL DRUG PRICE SPREAD MAY PROMPT MEDICARE PAYMENT CHANGE
RENAL DRUG PRICE SPREAD MAY PROMPT MEDICARE PAYMENT CHANGE
May 5, 2004
Manufacturers of certain kidney disease drugs could soon face a marketing challenge and revenue pressures if the Centers for Medicare & Medicaid Services (CMS) responds to a price report from the HHS Office of Inspector General (OIG) by adjusting Medicare reimbursements for those drugs.